The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.

Detalimogene voraplasmid (detalimogene; formerly EG-70) demonstrated promising responses in patients with high-risk Bacillus ...

Understanding changes, seeking support, and staying connected can help caregivers adapt to the challenges of secondary progressive MS.

People receiving unregulated Botox treatment are placing themselves at a “serious risk of harm”, according to a medical ...

-- 63% complete response (CR) rate at any time (n=62); -- 56% CR rate at 3 months (n=62); -- 62% CR rate at 6 months (n=37), with 4 patients having successfully converted to CR post reinduction; and - ...

Many women feel sharp, shooting pain in the vagina during their periods and doctors say it's more common, more misunderstood, ...

A man who hasn’t been able to feel anything in his genitals since he was a teenager says he is ‘sleepwalking through life’ ...

MARK Beattie was sitting at his computer when, at just 14, he suddenly lost all feeling in his penis. “I can remember it was ...

Mark Beattie, 32, from Newtownabbey in Co Antrim, said he was sitting at his computer one day in his teenage years when he ...

These subgroup insights will guide trial design, patient selection, and endpoint strategy for Autonomix's upcoming U.S.-based multicenter clinical study, currently planned to begin in 2026, which will ...

Mark Beattie said he was sitting at his computer one day in his teenage years when he recalled feeling a sudden "freak out" ...

EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing ...